Loading candles…
Suven Life Sciences Ltd is a clinical-stage biopharmaceutical company headquartered in Hyderabad, India, specializing in the development of novel therapeutics for neurodegenerative disorders. The company is research-driven and focuses on the discovery and development of New Chemical Entities (NCEs) aimed at addressing unmet medical needs in conditions such as Alzheimer's disease, Major Depressive Disorder, and Narcolepsy. Operating within the biopharmaceutical and pharmaceutical industries, Suven Life Sciences centers its business model on high-risk, high-reward drug discovery with substantial investments in research and development. Unlike traditional pharmaceutical companies that primarily engage in generic drug manufacturing, Suven Life Sciences concentrates on Central Nervous System (CNS) disorders, reflecting a specialized approach to drug development within India.
This page is a live market overview for SUVEN LIFE SCIENCES LTD (SUVEN) on the NSE. As a listed security, SUVEN LIFE SCIENCES LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for SUVEN before placing trades on tick2trade.
As of the latest feed, SUVEN last traded at ₹318.4 on NSE, up ₹0.6 (0.19%) from the previous close of ₹317.8. Today's session range is ₹312 – ₹324.25, against a 52-week band of ₹124.11 – ₹371. Traded volume today stands at 4.87L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for SUVEN in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether SUVEN is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for SUVEN LIFE SCIENCES LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in SUVEN. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated SUVEN option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 6 Aug 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 29 Jan 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 11 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 13 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and Fund Raising | 13 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.